The International Cartilage Regeneration & Joint Preservation Society (ICRS) has named Daniel A. Grande, PhD, assistant vice president of research services and professor of molecular medicine and orthopedic surgery at The Feinstein Institutes for Medical Research, its new President-Elect. Dr. Grande will serve a two-year term, followed by an additional two-year term as the esteemed past president on the ICRS Executive Board.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240418363701/en/
Feinstein Institutes’ Dr. Daniel A. Grande has been named the new president-elect of International Cartilage Repair Society. (Credit: Feinstein Institutes)
Dr. Grande, renowned for his significant contributions to cartilage repair and regeneration, will lead the ICRS in its mission to advance science and education in preventing and treating cartilage injuries. His expertise and leadership will help drive the society's initiatives and foster new collaborations among research professionals globally.
"For more than thirty years, I have focused my research on cartilage repair to advance our understandings and find new treatments for our patients,” said Dr. Grande, professor at the Feinstein Institutes' Institute of Bioelectronic Medicine. "I am honored and excited to serve as the President-Elect of the International Cartilage Regeneration & Joint Preservation Society. I look forward to working closely with the ICRS community to further our shared goals and continue advancing the cartilage repair and regeneration field."
Dr. Grande is a pioneer in cell-based therapies for articular cartilage repair. His research led to the FDA-approved autologous chondrocyte implantation, now the standard treatment for focal cartilage defects. While initially focusing on cartilage repair, Dr. Grande has broadened his expertise to include tissue engineering, stem cells, biomaterials, and biomechanics, exploring areas like the meniscus, intervertebral disc, tendon, and bone and the emerging field of 3D bioprinting.
He has published more than 100 peer-reviewed articles in top journals, including Nature Reviews Rheumatology and Clinical Orthopedics, and has contributed to book chapters and editorials. Recently, his lab pioneered 3D bioprinting applications and collaborated with other departments on biomaterials and tracheal reconstruction. Most recently, he published in the Journal of Cartilage & Joint Preservation, looking at extracellular vesicles (EVs) from mesenchymal stem cells (MSCs) believed to help in cartilage regeneration, and helped redefine orthobiologics in the Open Journal of Regenerative Medicine.
“Dr. Grande founded the orthopedic research lab at the Feinstein Institutes and continues to explore innovative regenerative therapies, including stem cells and 3D bioprinting," said Kevin J. Tracey, MD, president and CEO of the Feinstein Institutes and Karches Family Distinguished Chair in Medical Research. “On behalf of our 5,000 researchers and staff, we congratulate Dr. Grande on his election to the ICRS and look forward to his continued leadership.”
The ICRS is a prominent international society dedicated to the advancement of cartilage research, focusing on the prevention and treatment of cartilage injuries. With a network of leading experts and researchers from around the world, the society plays a pivotal role in promoting innovative research, education, and clinical practice in the field of cartilage repair.
About the Feinstein Institutes
The Feinstein Institutes for Medical Research is the home of the research institutes of Northwell Health, the largest health care provider and private employer in New York State. Encompassing 50 research labs, 3,000 clinical research studies and 5,000 researchers and staff, the Feinstein Institutes raises the standard of medical innovation through its five institutes of behavioral science, bioelectronic medicine, cancer, health system science, and molecular medicine. We make breakthroughs in genetics, oncology, brain research, mental health, autoimmunity, and are the global scientific leader in bioelectronic medicine – a new field of science that has the potential to revolutionize medicine. For more information about how we produce knowledge to cure disease, visit http://feinstein.northwell.edu and follow us on LinkedIn.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240418363701/en/
Contacts
Matthew Libassi
631-793-5325
mlibassi@northwell.edu
